Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000069.xml
Semin Liver Dis 2002; 22(4): 325-338
DOI: 10.1055/s-2002-35703
DOI: 10.1055/s-2002-35703
Animal Models of Autoimmune Hepatitis
Elmar Jaeckel- Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts
Further Information
Publication History
Publication Date:
25 November 2002 (online)
ABSTRACT
Autoimmune hepatitis (AIH) is difficult to study in humans because of the late diagnosis, the heterogenic genetic background and the lack of tissue specimens. Therefore, animal models have been used for more than 90 years to study liver-specific immune regulation. This article summarizes how early studies of experimental AIH established the importance of T cells for causing the liver injury and how regulatory pathways were detected. Studies in transgenic models demonstrated that T cells can be tolerant to liver antigens by ignorance, deletion, anergy, and receptor downregulation. They furthermore defined functions in antigen presentation for hepatocytes and sinusoidal endothelial cells. Studies in cytokine-induced models show common effector cascades resulting from T-cell activation and the interaction of innate and adaptive immune response. The use of animal models of AIH will improve our understanding of the pathophysiology of the disease and might help to explore new possibilities for therapy and prevention.
KEYWORDS
Experimental autoimmune hepatitis - tolerance - anergy - deletion - immune regulation - cytokines - regulatory cells
REFERENCES
- 1 Vyse T J, Todd J A. Genetic analysis of autoimmune disease. Cell . 1996; 85 311-318
- 2 Encinas J A, Wicker L S, Peterson L B. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2. Nat Genet . 1999; 21 158-160
- 3 Vafiadis P, Bennett S T, Todd J A. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet . 1997; 15 289-292
- 4 Pugliese A, Zeller M, Fernandez Jr A. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet . 1997; 15 293-297
- 5 Waldenstroem J. Leber, Blutproteine, Nahrungseiweisse. Dtsch Gesellschaft fuer Verdauung und Stoffwechsel . 1950; 15 113-119
-
6 Fiessinger N, ed. Histogenèse des processus de cirrhose hépatique. Lésion parenchymateuse et cirrhose. Paris: 1908
- 7 Casals J, Olitsky P K. Tests for hepatic dysfunction in mice. Proc Soc Exp Biol . 1946; 63 383-389
- 8 Behar A J, Tal C. Experimental liver necrosis produced by injection of homologous whole liver with adjuvant. J Pathol Bacteriol . 1959; 77 591-596
- 9 Matzinger P. An innate sense of danger. Ann NY Acad Sci . 2002; 961 341-342
- 10 Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol . 1994; 12 991-1045
- 11 Dodd M C, Bigley N J, Geyer V B. Autoimmune response in rabbits injected with rat liver ribosomes. Science . 1962; 137 688-689
- 12 Warnatz H, Scheiffarth F, Schwarz R. Animal experiment studies on the pathogenesis of chronic hepatitis. II. Serological studies following sensitization with homologous liver cell fractions. Virchows Arch Pathol Anat Physiol Klin Med . 1965; 339 364-371
- 13 Scheiffarth F, Warnatz H, Niederer W. Tierexperimentelle Studien zur Pathogenese der chronischen Hepatitis. I. Mitteilung. Morphologische Studien an der Leber nach Sensibilisierung mit homologen Leberzellfraktionen. Virchows Arch A Pathol Anat Histol . 1965; 339 358-365
- 14 Wies I, Brunner S, Henninger J. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet . 2000; 355 1510-1515
- 15 Costa M, Rodriguez-Sanchez J L, Czaja A J. Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis. Clin Exp Immunol . 2000; 121 364-374
- 16 Volkmann M, Martin L, Baurle A. Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis. Hepatology . 2001; 33 591-596
- 17 Meyer zum Buschenfelde H K, Kössling F K, Miescher P A. Experimental chronic active hepatitis in rabbits following immunization with human liver proteins. Clin Exp Immunol . 1972; 10 99-108
- 18 McFarlane I G, Wojcicka B M, Zucker G M. Purification and characterization of human liver-specific membrane lipoprotein (LSP). Clin Exp Immunol . 1977; 27 381-390
- 19 Kössling F K, Meyer zum Büschenfelde K H. Zur Induktion einer aktiven chronischen Hepatitis durch heterologe Leberproteine. Virchows Arch A Pathol Anat Histol . 1968; 345 365-376
- 20 Meyer zum Buschenfelde H K, Hopf U. Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins. Br J Exp Pathol . 1974; 55 498-508
- 21 Hopf U, Meyer zum Buschenfelde H K, Hutteroth T. Humoral immune reactions on the hepatocellular plasma membrane in the experimental chronic active hepatitis in rabbits [in German]. Klin Wochenschr . 1976; 54 591-598
- 22 Hopf U, Meyer zum Buschenfelde H K. Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. II. Demonstration of immunoglobulin on isolated hepatocytes. Br J Exp Pathol . 1974; 55 509-513
- 23 Feighery C, McDonald G S, Greally J F. Histological and immunological investigation of liver-specific protein (LSP) immunized rabbits compared with patients with liver disease. Clin Exp Immunol . 1981; 45 143-151
- 24 Uibo R M, Helin H J, Krohn K J. Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits. Clin Exp Immunol . 1982; 48 505-512
- 25 Feighery C, Weir D G. How specific is liver-specific protein?. Gastroenterology . 1980; 79 179-180
- 26 Scheiffarth F, Warnatz H, Mayer K. Studies concerning the importance of mononuclear cells in the development of experimental hepatitis. J Immunol . 1967; 98 396-401
- 27 Warnatz H, Scheiffarth F, Schmeissner R. Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells. Clin Exp Immunol . 1975; 21 250-258
- 28 Kuriki J, Murakami H, Kakumu S. Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae. Gastroenterology . 1983; 84 596-603
- 29 Mori Y, Mori T, Yoshida H. Study of cellular immunity in experimental autoimmune hepatitis in mice. Clin Exp Immunol . 1984; 57 85-92
- 30 Mori Y, Mori T, Ueda S. Study of cellular immunity in experimental autoimmune hepatitis in mice: transfer of spleen cells sensitized with liver proteins. Clin Exp Immunol . 1985; 61 577-584
- 31 Mori T, Mori Y, Yoshida H. Cell-mediated cytotoxicity of sensitized spleen cells against target liver cells-in vivo and in vitro study with a mouse model of experimental autoimmune hepatitis. Hepatology . 1985; 5 770-777
- 32 Araki K, Yamamoto H, Fujimoto S. Studies on the pathogenesis of murine experimental autoimmune active hepatitis: sensitized T cell involvement in its induction. Clin Exp Immunol . 1987; 67 326-334
- 33 Bartholomaeus W N, O'Donoghue H, Reed W D. Thymus-dependence of autoantibody responses to liver specific lipoprotein in the mouse. Clin Exp Immunol . 1984; 55 541-545
- 34 Watanabe Y, Kawakami H, Kawamoto H. Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice. Clin Exp Immunol . 1987; 67 105-113
- 35 Asano M, Toda M, Sakaguchi N. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med . 1996; 184 387-396
- 36 Shevach E M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol . 2002; 2 389-400
- 37 Lohse A W, Manns M, Dienes H P. Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology . 1990; 11 24-30
- 38 Lohse A W, Brunner S, Kyriatsoulis A. Autoantibodies in experimental autoimmune hepatitis. J Hepatol . 1992; 14 48-53
- 39 Lohse A W, Meyer zum Buschenfelde H K. Remission of experimental autoimmune hepatitis is associated with antigen-specific and non-specific immunosuppression. Clin Exp Immunol . 1993; 94 163-167
- 40 Lohse A W, Kogel M, Meyer zum Buschenfelde H K. Evidence for spontaneous immunosuppression in autoimmune hepatitis. Hepatology . 1995; 22 381-388
- 41 Suri-Payer E, Amar A Z, Thornton A M. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol . 1998; 160 1212-1218
- 42 Thornton A M, Shevach E M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med . 1998; 188 287-296
- 43 Lohse A W, Dienes H P, Meyer zum Buschenfelde H K. Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression. Hepatology . 1998; 27 1536-1543
- 44 Derbinski J, Schulte A, Kyewski B. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol . 2001; 2 1032-1039
- 45 Klein L, Kyewski B. ``Promiscuous'' expression of tissue antigens in the thymus: a key to T-cell tolerance and autoimmunity?. J Mol Med . 2000; 78 483-494
- 46 Klein L, Klein T, Ruther U. CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J Exp Med . 1998; 188 5-16
- 47 Jones-Youngblood S L, Wieties K, Forman J. Effect of the expression of a hepatocyte-specific MHC molecule in transgenic mice on T cell tolerance. J Immunol . 1990; 144 1187-1195
- 48 Wieties K, Hammer R E, Jones-Youngblood S. Peripheral tolerance in mice expressing a liver-specific class I molecule: inactivation/deletion of a T-cell subpopulation. Proc Natl Acad Sci U S A . 1990; 87 6604-6608
- 49 Morahan G, Brennan F E, Bhathal P S. Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc Natl Acad Sci U S A . 1989; 86 3782-3786
- 50 Moriyama T, Guilhot S, Klopchin K. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science . 1990; 248 361-364
- 51 Chisari F V, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol . 1995; 13 29-60
- 52 Chisari F V. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol . 1996; 206 149-173
- 53 Wirth S, Guidotti L G, Ando K. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice. J Immunol . 1995; 154 2504-2515
- 54 Shimizu Y, Guidotti L G, Fowler P. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol . 1998; 161 4520-4529
- 55 Ando K, Guidotti L G, Wirth S. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol . 1994; 152 3245-3253
- 56 Ando K, Moriyama T, Guidotti L G. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med . 1993; 178 1541-1554
- 57 Ando K, Guidotti L G, Cerny A. CTL access to tissue antigen is restricted in vivo. J Immunol . 1994; 153 482-488
- 58 Ferber I, Schonrich G, Schenkel J. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science . 1994; 263 674-676
- 59 Schonrich G, Kalinke U, Momburg F. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell . 1991; 65 293-304
- 60 Schonrich G, Alferink J, Klevenz A. Tolerance induction as a multi-step process. Eur J Immunol . 1994; 24 285-293
- 61 Alferink J, Schittek B, Schonrich G. Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance. Int Immunol . 1995; 7 331-336
- 62 Schonrich G, Momburg F, Malissen M. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int Immunol . 1992; 4 581-590
- 63 Heath W R, Allison J, Hoffmann M W. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature . 1992; 359 547-549
- 64 Limmer A, Sacher T, Alferink J. Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment. Eur J Immunol . 1998; 28 2395-2406
- 65 Bertolino P, Heath W R, Hardy C L. Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol . 1995; 25 1932-1942
- 66 Rocha B, von Boehmer H. Peripheral selection of the T cell repertoire. Science . 1991; 251 1225-1228
- 67 Bertolino P, Trescol-Biemont M C, Rabourdin-Combe C. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur J Immunol . 1998; 28 221-236
- 68 Bertolino P, Trescol-Biemont M C, Thomas J. Death by neglect as a deletional mechanism of peripheral tolerance. Int Immunol . 1999; 11 1225-1238
- 69 Huang L, Soldevila G, Leeker M. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity . 1994; 1 741-749
- 70 Bertolino P, Bowen D G, McCaughan G W. Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol . 2001; 166 5430-5438
- 71 Voehringer D, Blaser C, Grawitz A B. Break of T cell ignorance to a viral antigen in the liver induces hepatitis. J Immunol . 2000; 165 2415-2422
- 72 Oldstone M B, Nerenberg M, Southern P. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell . 1991; 65 319-331
- 73 Ohashi P S, Oehen S, Buerki K. Ablation of ``tolerance'' and induction of diabetes by virus infection in viral antigen transgenic mice. Cell . 1991; 65 305-317
- 74 Limmer A, Ohl J, Kurts C. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med . 2000; 6 1348-1354
- 75 Knolle P A, Schmitt E, Jin S. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward TH1 cells. Gastroenterology . 1999; 116 1428-1440
- 76 Lohse A W, Knolle P A, Bilo K. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology . 1996; 110 1175-1181
- 77 Tiegs G. Experimental hepatitis and role of cytokines. Acta Gastroenterol Belg . 1997; 60 176-179
- 78 Toyonaga T, Hino O, Sugai S. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc Natl Acad Sci USA . 1994; 91 614-618
- 79 Hussain M J, Mustafa A, Gallati H. Cellular expression of tumour necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease. J Hepatol . 1994; 21 816-821
- 80 Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest . 1992; 90 196-203
- 81 Kusters S, Gantner F, Kunstle G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology . 1996; 111 462-471
- 82 Gantner F, Leist M, Lohse A W. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology . 1995; 21 190-198
- 83 Gantner F, Leist M, Kusters S. T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release. Exp Cell Res . 1996; 229 137-146
- 84 Knolle P A, Gerken G, Loser E. Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice. Hepatology . 1996; 24 824-829
- 85 Takeda K, Hayakawa Y, Van Kaer L. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA . 2000; 97 5498-5503
- 86 Gantner F, Leist M, Jilg S. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology . 1995; 109 166-176
- 87 Leist M, Gantner F, Bohlinger I. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol . 1994; 153 1778-1788
- 88 Kuhn R, Lohler J, Rennick D. Interleukin-10-deficient mice develop chronic enterocolitis. Cell . 1993; 75 263-274
- 89 Shull M M, Ormsby I, Kier A B. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature . 1992; 359 693-699
- 90 Gorham J D, Lin J T, Sung J L. Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J Immunol . 2001; 166 6413-6422
- 91 Clemente M G, Obermayer-Straub P, Meloni A. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab . 1997; 82 1353-1361
- 92 Clemente M G, Meloni A, Obermayer-Straub P. Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology . 1998; 114 324-328
- 93 Obermeyer-Straub P, Perheentupa J, Braun S. Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Gastroenterology . 2001; 121 668-677